HORIZON-EIC-2023-TRANSITIONCHALLENGES-01
EIC Transition Challenge: Full scale Micro-Nano-Bio devices for medical and medical research applications
Plain-language summary
EIC Transition Challenge funds full-scale micro-nano-bio devices for medical and research applications.
This call supports the development of advanced micro-nano-bio devices for healthcare and medical research. It aims to bridge the gap between research and market-ready products. Funding is provided through multiple cut-off dates for submissions.
Likely relevant for
- Medical device developers
- Biomedical researchers
- Micro-nano technology innovators
- Health technology startups
Project signals
Focus on full-scale device developmentApplications in medical or medical research fieldsAlignment with digital and AI agendas
What it funds
- Development of full-scale micro-nano-bio devices
- Applications in medical diagnostics, treatment, or research
- Projects bridging research and market deployment
Expected outcomes
- Market-ready or near-market medical devices
- Innovations integrating micro, nano, and bio technologies
- Advancements supporting medical research capabilities
Who can apply / participate
- SMEs
- Startups
- Research organizations
- Universities
- Industry partners
- Check if single applicants or consortia are allowed
- EU Member States and associated countries
- Applicants must demonstrate relevant expertise and innovation potential
- Exact consortium composition rules
- Specific eligibility conditions
Must check before shortlisting
- Specific eligibility criteria and consortium requirements
- Budget and funding rate details
- Exact submission deadlines and cut-off dates
Money
Budget and funding rates are not clearly stated and must be verified.
Application notes
- Multiple cut-off dates allow for several submission opportunities before the final deadline.
- Confirm exact submission deadlines for each cut-off
- Verify required documents and templates
Derived from official EU Funding portal source · updated 2 Jul 2026, 10:25 UTC. Use this as a shortlisting aid; the official call text remains authoritative.
Official source text
Fine print from the EU source record. Expand when you need the original wording.